You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CIN 2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervix Uteri SIL, HPV, CIN2 Trial in Prague (Colposcopy)

Recruiting
  • Cervix Uteri SIL
  • +3 more
  • Colposcopy
  • Prague, Czechia
    General University Hospital
Nov 24, 2023

Cervical Intraepithelial Neoplasia Grade 2, DNA Methylation Trial in Maribor (Testing DNA methylation test for predicting

Recruiting
  • Cervical Intraepithelial Neoplasia Grade 2
  • DNA Methylation
  • Testing DNA methylation test for predicting prognosis of untreated CIN 2
  • Maribor, Slovenia
    University Medical Centre Maribor
Nov 14, 2022

Cervical Intraepithelial Neoplasia, Cervical Dysplasia Trial in New Haven (9-valent HPV vaccine, Imiquimod)

Active, not recruiting
  • Cervical Intraepithelial Neoplasia
  • Cervical Dysplasia
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 5, 2022

Magnetic Resonance Imaging Examination Trial in Wenzhou (MRI,SCC-Ag)

Recruiting
  • Magnetic Resonance Imaging Examination
  • MRI,SCC-Ag
  • Wenzhou, Zhejiang, China
    The 2nd Affiliated Hospital and Yuying Children's Hospital of WM
Aug 3, 2022

Intra-epithelial Histological Lesions of High Grade Cervical

Recruiting
  • HPV Infection
  • Cervical Cancer
  • abstention from CIN2 treatment and surveillance for at least 2 years
  • Bordeaux, France
    CHU Bordeaux
Apr 11, 2022

Irritable Bowel Syndrome With Diarrhea Trial (CIN-103, Placebo)

Not yet recruiting
  • Irritable Bowel Syndrome With Diarrhea
  • (no location specified)
Nov 22, 2023

Cervical Cancer, Genital Wart, CIN1 Trial (Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine

Not yet recruiting
  • Cervical Cancer
  • +11 more
  • Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha)
  • Placebo
  • (no location specified)
Oct 17, 2022

CIN 2/3, HIV Trial in Lilongwe (Intravaginal 5-Fluorouracil (5-FU))

Not yet recruiting
  • CIN 2/3
  • HIV Infections
  • Intravaginal 5-Fluorouracil (5-FU)
  • Lilongwe, Malawi
    UNC Project, Kamuzu Central Hospital
Jan 17, 2023

Cervical Cancer, CIN2, CIN3 Trial in Westdene (5 Fluorouracil (5 FU) Cream, Placebo)

Not yet recruiting
  • Cervical Cancer
  • +4 more
  • 5 Fluorouracil (5 FU) Cream
  • Placebo
  • Westdene, Johannesburg, South Africa
    Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospita
Nov 30, 2022

After Whole Vaccination Shcedule With Recombination Quadrivalent

Not yet recruiting
  • HPV Infections
  • +6 more
    • (no location specified)
    May 7, 2022

    Cervical Cancer, CIN2, CIN3 Trial in Westdene (Urine HPV testing, Self-collected cervicovaginal specimen, Provider-collected

    Not yet recruiting
    • Cervical Cancer
    • +2 more
    • Urine HPV testing
    • +2 more
    • Westdene, Johannesburg, South Africa
      Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospita
    Sep 14, 2022

    Primary Aldosteronism, Hyperaldosteronism Trial in United States (CIN-107 2 mg dosing, CIN-107 4 mg dosing, CIN-107 8 mg dosing)

    Recruiting
    • Primary Aldosteronism
    • Hyperaldosteronism
    • CIN-107 2 mg dosing
    • +2 more
    • Los Angeles, California
    • +7 more
    Feb 1, 2023

    Papilloma Viral Infection, CIN1, LSIL, Low Grade Squamous Intraepithelial Lesion Trial in Madrid (Glizigen, Placebo)

    Recruiting
    • Papilloma Viral Infection
    • +2 more
    • Glizigen
    • Placebo
    • Madrid, Spain
    • +3 more
    Jun 27, 2023

    Cervical Cancer, Genital Warts Trial (Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine, Matching Placebo)

    Active, not recruiting
    Has Results
    • Cervical Cancer
    • Genital Warts
    • Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine
    • Matching Placebo
    • (no location specified)
    Aug 22, 2022

    Human Immunodeficiency Virus, HPV Infection, CIN 2/3 Trial in Kisumu (Thermocoagulation)

    Completed
    Has Results
    • Human Immunodeficiency Virus
    • +2 more
    • Thermocoagulation
    • Kisumu, Kenya
      Kenya Medical Research Institute
    Jan 5, 2023

    Long-Term Follow-Up of HPV FOCAL Participants

    Active, not recruiting
    • Cervical Cancer
    • HPV and cytology co-testing (via Liquid based collection device)
    • Vancouver, British Columbia, Canada
      Women's Health Research Institute
    Oct 31, 2022

    Predictive for Cervical Intraepithelial Neoplasia Grade 2

    Active, not recruiting
    • Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
      • Herning, Region Of Central Jutland, Denmark
        Department of Gynecology and Obstetrics, Herning Regional Hospit
      Sep 9, 2021

      HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Guangxi (Experimental: Experimental: 9-valent Human Papillomavirus

      Completed
      • HPV Infections
      • +14 more
      • Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
      • Active Comparator: GARDASIL ®9
      • Guangxi, China
        Guangxi Zhuang Autonomous Region Center for Disease Control and
      May 9, 2022

      HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Hangzhou (9-valent HPV vaccine)

      Recruiting
      • HPV Infections
      • +14 more
      • 9-valent HPV vaccine
      • Hangzhou, China
        Huakun Lv
      Feb 23, 2022

      Diabetic Gastroparesis Trial in United States (CIN-102 Dose 1, CIN-102 Dose 2, Placebo)

      Recruiting
      • Diabetic Gastroparesis
      • CIN-102 Dose 1
      • +2 more
      • Tucson, Arizona
      • +19 more
      Apr 14, 2023

      HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer Trial in Mianyang (2-doses Group among 9-14 years, 3-doses Group among

      Recruiting
      • HPV Infections
      • +6 more
      • 2-doses Group among 9-14 years
      • +2 more
      • Mianyang, Sichuan, China
        Center for Disease Control and Prevention
      Feb 23, 2022

      Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Yangchun (4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL®)

      Completed
      • Cervical Cancer
      • +13 more
      • 4-valent HPV Vaccine
      • +2 more
      • Yangchun, Guangdong, China
        Yangchun Center For Disease Prevention And Control
      Feb 23, 2022

      Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Rongan County (9-valent Human Papillomavirus (Types 6, 11, 16,

      Recruiting
      • Cervical Cancer
      • +13 more
      • 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha)
      • GARDASIL®
      • Rongan County, Guangxi Zhuang Autonomous Region, China
        Rongan County Center for Disease Control and Prevention
      Feb 20, 2022

      Hypertension Trial in United States (CIN-107)

      Recruiting
      • Hypertension
      • Huntington Park, California
      • +14 more
      Jul 14, 2022

      Cervical Dysplasia, HPV Infection Trial in Ulaanbaatar (gel Interferon arm, gel Interferon and interferon suppository arm)

      Recruiting
      • Cervical Dysplasia
      • HPV Infection
      • gel Interferon arm
      • gel Interferon and interferon suppository arm
      • Ulaanbaatar, Mongolia
        National Cancer Center
      Nov 14, 2023